Deal Announcements

Allylix Adds $18 Million Venture Capital Funding

Tuesday, March 13, 2012 5:31:00 AM PDT | VentureDeal Staff

   San Diego, California  --  Biotechnology company Allylix has landed $18.2 million in new venture capital and strategic investment.

Allylix is developing terpenes at low cost for commercial applications in a variety of industries.

BASF Venture Capital leather round, which also included Cultivian Ventures and other investors.

The funding will support development and delivery of new chemical products and expanding applications for its existing products.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1